Period | Screening | Baseline | Treatment (weeks 1–12) | Follow-up (weeks 13–48) | ||
---|---|---|---|---|---|---|
Week | Week 0 | Week 0 | Week 6 | Week 12 | Week 24 | Week 48 |
Eligibility | × | |||||
Demographic medical history | × | |||||
Informed consent | × | |||||
Basic laboratory test® | × | × | × | |||
24-h ABPM | × | × | × | |||
TCM syndrome score, SF-36 | × | × | × | |||
NIHSS, BI | × | × | × | |||
ESRS | × | × | ||||
Follow-up BP | × | × | ||||
Recurrence of stroke | × | |||||
NO, ET, Hcy, sCD40L, Copeptin | × | × | × | |||
ECG | × | × | × | |||
Chest X-ray | × | |||||
Color Doppler ultrasound® | × | × | ||||
All-cause mortality rate | × | |||||
Combined diseases and drugs | Record at any time | |||||
Antihypertensive medication adjustment | Record at any time | |||||
Adverse event | Record at any time | |||||
Daily BP | Record everyday (based on BP diary) | |||||
Safety of acupuncture | Record at any time | |||||
Patients’ compliance | × |